"Mount Nittany Health, a health system located in State College, Pennsylvania, consists of Mount Nittany Medical Center, a 260-bed acute care facility, and Mount Nittany Physician Group, a staff of more than 160 providers who offer primary and specialty care services at a growing number of offices throughout central Pennsylvania. In addition to providing high quality care, Mount Nittany Health strives to improve the health and wellness of its community through education programs, events and health screenings. Visit our website to learn more about Mount Nittany Health’s mission to make people healthier."

During the past decade, Mount Nittany Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 71 clinical trials were completed, i.e. on average, 591.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 25 clinical trials were completed. i.e. 2500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Nittany Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "Eastern Cooperative Oncology Group" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "Radiation Therapy Oncology Group" with 9 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Nittany Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 65 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator and "Eastern Cooperative Oncology Group" with 8 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Mount Nittany Medical Center" are "Breast Cancer" (19 trials), "Lymphoma" (9 trials), "Lung Cancer" (8 trials), "Recurrent Breast Carcinoma" (5 trials) and "Breast Adenocarcinoma" (4 trials). Many other conditions were trialed in "Mount Nittany Medical Center" in a lesser frequency.

Most popular intervention types in "Mount Nittany Medical Center" are "Drug" (94 trials), "Biological" (50 trials), "Other" (45 trials), "Radiation" (22 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "cyclophosphamide" (11 trials), "Quality-of-Life Assessment" (10 trials), "Bevacizumab" (9 trials) and "Cyclophosphamide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Mount Nittany Medical Center" are 90 trials for "All" genders, 22 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Mount Nittany Medical Center". undefined are not yet recruiting, 5 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Mount Nittany Medical Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Nittany Medical Center, 2 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".